Jefferies Group LLC Sage Therapeutics, Inc. Call Options Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Sep 21, 2023	BUY	$32.28 - $43.27 $413,184 - $553,856	12,800 Added 51.2%	37,800 $1.48 Million
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $413,184 - $553,856	12,800 Added 51.2%	37,800 $1.48 Million
Q1 2022 Sep 21, 2023	BUY	$30.71 - $45.71 $614,200 - $914,200	20,000 Added 400.0%	25,000 $827,000
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $614,200 - $914,200	20,000 Added 400.0%	25,000 $828,000
Q3 2021 Sep 21, 2023	SELL	$40.26 - $57.37 $785,070 - $1.12 Million	-19,500 Reduced 79.59%	5,000 $221,000
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $785,070 - $1.12 Million	-19,500 Reduced 79.59%	5,000 $222,000
Q2 2021 Sep 21, 2023	SELL	$54.88 - $79.29 $1.15 Million - $1.67 Million	-21,000 Reduced 46.15%	24,500 $1.39 Million
Q2 2021 Aug 20, 2021	SELL	$54.88 - $79.29 $133 Million - $192 Million	-2,425,500 Reduced 99.0%	24,500 $1.39 Million
Q2 2021 Aug 16, 2021	BUY	$54.88 - $79.29 $132 Million - $191 Million	2,404,500 Added 5284.62%	2,450,000 $1.39 Million
Q1 2021 Sep 21, 2023	BUY	$70.65 - $96.76 $1.2 Million - $1.64 Million	17,000 Added 59.65%	45,500 $3.41 Million
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $1.2 Million - $1.64 Million	17,000 Added 59.65%	45,500 $3.41 Million
Q4 2020 Sep 21, 2023	SELL	$58.41 - $89.06 $543,213 - $828,258	-9,300 Reduced 24.6%	28,500 $2.47 Million
Q3 2020 Nov 13, 2020	SELL	$41.13 - $62.45 $3.29 Million - $5 Million	-80,000 Reduced 73.73%	28,500 $1.74 Million
Q4 2019 Feb 13, 2020	BUY	$60.18 - $154.77 $3.08 Million - $7.92 Million	51,200 Added 89.35%	108,500 $7.83 Million
Q3 2019 Nov 13, 2019	SELL	$140.29 - $189.96 $2.62 Million - $3.55 Million	-18,700 Reduced 24.61%	57,300 $8.04 Million
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $1.85 Million - $2.14 Million	11,700 Added 18.2%	76,000 $13.9 Million
Q1 2019 May 15, 2019	BUY	$89.33 - $163.65 $973,697 - $1.78 Million	10,900 Added 20.41%	64,300 $10.2 Million
Q4 2018 Feb 14, 2019	BUY	$81.94 - $139.71 $4.38 Million - $7.46 Million	53,400 New	53,400 $5.12 Million

Others Institutions Holding SAGE

# of Institutions

198

Shares Held

46.5M

Call Options Held

402K

Put Options Held

209K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account